These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 19479389)
1. [Immunosuppression after heart and lung transplantation]. Wendler O; Schäfers HJ Med Klin (Munich); 1997 Dec; 92 Suppl 5():3-7. PubMed ID: 19479389 [TBL] [Abstract][Full Text] [Related]
2. New immunosuppressive regimens in lung transplantation. Briffa N; Morris RE Eur Respir J; 1997 Nov; 10(11):2630-7. PubMed ID: 9426106 [TBL] [Abstract][Full Text] [Related]
3. Current trends in immunosuppression for lung transplantation. Floreth T; Bhorade SM Semin Respir Crit Care Med; 2010 Apr; 31(2):172-8. PubMed ID: 20354930 [TBL] [Abstract][Full Text] [Related]
4. Early treatment of acute rejection prevents chronic rejection in a rat model of allogenic left lung transplantation. Hirt SW; You XM; Möller F; Boeke K; Ernst M; Starke M; Spranger U; Wottge HU Transplant Proc; 1998 Jun; 30(4):1005-6. PubMed ID: 9636406 [No Abstract] [Full Text] [Related]
7. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681 [TBL] [Abstract][Full Text] [Related]
8. Survival after bronchiolitis obliterans syndrome. Yerkovich ST; Hopkins PM; Chambers DC Am J Respir Crit Care Med; 2011 Feb; 183(4):554; author reply 554-5. PubMed ID: 21325085 [No Abstract] [Full Text] [Related]
9. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients. Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986 [TBL] [Abstract][Full Text] [Related]
10. Experience with cyclosporine: from revolution to evolution of immunosuppressive protocols in thoracic organ transplantation. Haverich A; Gorler H Transplant Proc; 2004 Mar; 36(2 Suppl):314S-317S. PubMed ID: 15041360 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppression for lung transplantation. Bhorade SM; Stern E Proc Am Thorac Soc; 2009 Jan; 6(1):47-53. PubMed ID: 19131530 [TBL] [Abstract][Full Text] [Related]
15. Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients. Singh TP; Faber C; Blume ED; Worley S; Almond CS; Smoot LB; Dillis S; Nasman C; Boyle GJ J Heart Lung Transplant; 2010 May; 29(5):517-22. PubMed ID: 20061164 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis, Pathophysiology and Experimental Models of Chronic Lung Allograft Rejection. Gauthier JM; Ruiz-Pérez D; Li W; Hachem RR; Puri V; Gelman AE; Kreisel D Transplantation; 2018 Sep; 102(9):1459-1466. PubMed ID: 29683998 [TBL] [Abstract][Full Text] [Related]
17. Impact of the severity of acute rejection in the early phase after rat lung transplantation on the effectiveness of mycophenolate mofetil to treat chronic allograft rejection. von Suesskind-Schwendi M; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K Eur J Cardiothorac Surg; 2012 Jul; 42(1):142-8. PubMed ID: 22398468 [TBL] [Abstract][Full Text] [Related]
18. FK 506 'rescue' immunosuppression for obliterative bronchiolitis after lung transplantation. Ross DJ; Lewis MI; Kramer M; Vo A; Kass RM Chest; 1997 Nov; 112(5):1175-9. PubMed ID: 9367453 [TBL] [Abstract][Full Text] [Related]
19. Immunosuppression: what's standard and what's new? Witt CA; Hachem RR Semin Respir Crit Care Med; 2013 Jun; 34(3):405-13. PubMed ID: 23821513 [TBL] [Abstract][Full Text] [Related]
20. Cytolytic induction therapy in heart and lung transplantation: the protagonist opinion. Wahlers T Transplant Proc; 1998 Jun; 30(4):1100-3. PubMed ID: 9636447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]